Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

As rates of respiratory illness decline across the region following the most severe flu season since 2009, ChristianaCare ...

Peripheral Arterial Disease, or PAD, affects millions of people. PAD patients may struggle with disease management due to ...

Peripheral Artery Disease (PAD) is often referred to as a “silent killer” because many people don’t know they have it until ...

Adventist Health is welcoming board certified physician assistant Frederick “Gill” Gilliam, PA-C, to its Hanford and Fowler ...

A new international study has found that semaglutide, a medication commonly used to treat type 2 diabetes and obesity, ...

J&J’s new pivotal study in coronary artery disease, dubbed FORWARD CAD, will test a cardiac-focused version of the Javelin as ...

Semaglutide associated with increased walking distance in patients with symptomatic peripheral artery disease and type 2 diabetes.

Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic peripheral artery disease (PAD), according to results from the STRIDE trial ...

A shocking new study reveals that a condition that can lead to limb amputation is far more prevalent and deadly than ...